Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Storm Therapeutics Ltd.
Headquarters: Cambridge, United Kingdom
Website: https://www.stormtherapeuti...
Year Founded: 2015
Status: Private
BioCentury | Jan 15, 2025
Management Tracks
Auspitz becomes managing partner at Curie.bio
Plus: Amphista names Paul Medeiro CBO, and updates from Apellis, Forbion, Eqt, Egle, Spero, Molecular Templates and more
BioCentury | Sep 12, 2024
Management Tracks
Ovid promotes Alexander to COO
Plus: Tyra hires Warner as CMO and updates from Senisca, Closed Loop, NanoSyrinx and more
BioCentury | Feb 2, 2024
Finance
VC roundup: New funds for TCG and Seroba, rounds for Cour and Aqemia
Plus fresh cash for Halia and Neophore, and a new spinout from venture-backed Cumulus Oncology
BioCentury | Nov 1, 2023
Management Tracks
Genentech’s Hardy to become CEO at BioMarin
Plus: BMS CEO Boerner appointed chair, and updates from Storm, Amarin, CTRL, Lakewood, Vesica and RS
BioCentury | Jan 11, 2023
Management Tracks
Kevin Tan becomes CFO at Solid
Plus: Shook promoted to CMO at Nkarta, and updates from HilleVax, Neurotech, Akero, LifeSci, Dunad and more
BioCentury | Dec 15, 2022
Finance
Dec. 14 Quick Takes: Alpha-9 lands $75M for radiopharmaceutical pipeline
Plus: Avidity gains 55% on antibody-oligo conjugate data, and updates from Storm, Avidity, Kymera, Icosavax and more
BioCentury | Sep 7, 2022
Management Tracks
Harpoon’s McMahon becomes CEO at Storm
Plus new CFO, CSO at Voyager and updates from Sonoma, Garuda, Alloy, Homology and more
BioCentury | Oct 19, 2021
Product Development
Quick Takes: And then there were two — bluebird readies for split
Vertex’s Phase I diabetes data shine, plus United Therapeutics, Ipsen, Omeros and more
Items per page:
1 - 10 of 41